What is the P/E ratio of Gufic Pharma . - (Amalgamated)?

The latest standalone P/E ratio of Gufic Pharma . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Gufic Pharma . - (Amalgamated)?

The latest standalone P/B ratio of Gufic Pharma . - (Amalgamated) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Gufic Pharma . - (Amalgamated)?

The 52-week high of Gufic Pharma . - (Amalgamated) is Rs. and the 52-week low is Rs. .

Gufic Pharma Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

Name: Gufic Pharma . - (Amalgamated)
Brand: Gufic Pharma . - (Amalgamated)

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Gufic Pharma Ltd.

Based on:

Data

M-Cap below 100cr DeciZen not available

Gufic Pharma Ltd. - (Amalgamated) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

0 Cr.

52-wk low:

52-wk high:

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Gufic Pharma Ltd.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Dec'08	Dec'09	Dec'10	Mar'14	Mar'15	Mar'16	Mar'17	TTM
ROCE % ⓘ	7.1%	9.7%	19.3%	-6.1%	5.1%	6.8%	4.5%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	0
Sales YoY Gr.	-	NA	NA	NA	0%	0%	0%	-
Adj EPS ⓘ	35.5	52.1	120.4	-35.2	39.7	49.5	39.2	0
YoY Gr.	-	46.7%	131%	-129.3%	NA	24.9%	-20.8%	-
BVPS (₹) ⓘ	511.7	563.8	684.2	610	802.2	851.7	890.9	0
Adj Net Profit ⓘ	0	0	0.1	0	0	0	0	0
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	0	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	0%	0%
Adj EPS ⓘ	NA	-5.5%	NA	-20.8%
BVPSⓘ	NA	9.6%	13.5%	4.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Dec'08	Dec'09	Dec'10	Mar'14	Mar'15	Mar'16	Mar'17	TTM
Return on Equity % ⓘ	6.9	9.7	19.3	-6.1	5.1	6	4.5	0
Op. Profit Mgn % ⓘ	0	0	0	-45	63.9	77.6	63.3	NAN
Net Profit Mgn % ⓘ	0	0	0	-73.4	82.6	103.2	81.7	0
Debt to Equity ⓘ	0	0	0	0	0	0	0	-
Working Cap Days ⓘ	0	0	0	592	674	357	2,445	0
Cash Conv. Cycle ⓘ	0	0	0	0	0	0	0	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Gufic Pharma Ltd. - (Amalgamated)

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	-	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	100
Industry PE ⓘ	48.8

Management X-Ray of Gufic Pharma Ltd.:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Gufic Pharma Ltd.

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Gufic Pharma Ltd.

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Dec'08	Dec'09	Dec'10	Mar'14	Mar'15	Mar'16	Mar'17
Sales	0	0	0	0.03	0.02	0.02	0.02
Operating Expenses ⓘ	0.02	0	0.01	0.04	0.01	0.01	0.01
Manufacturing Costs	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0
Employee Cost	0	0	0	0	0	0	0
Other Costs ⓘ	0.02	0	0.01	0.04	0.01	0.01	0.01
Operating Profit ⓘ	-0.02	0	-0.01	-0.01	0.02	0.02	0.02
Operating Profit Margin (%)	-	-	-	-45.0%	63.9%	77.6%	63.3%
Other Income ⓘ	0.04	0.03	0.04	0	0.01	0.02	0.01
Interest ⓘ	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.02	0.03	0.03	-0.01	0.02	0.03	0.03
Tax ⓘ	0	0	-0.03	0.01	0	0.01	0.01
Profit After Tax	0.02	0.03	0.06	-0.02	0.02	0.02	0.02
PAT Margin (%)	-	-	-	-73.3%	82.6%	103.2%	81.7%
Adjusted EPS (₹)	35.5	52.1	120.4	-44.0	39.7	49.5	39.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Dec'08	Dec'09	Dec'10	Mar'14	Mar'15	Mar'16	Mar'17
Equity and Liabilities
Shareholders Fund	0.26	0.28	0.34	0.38	0.40	0.43	0.45
Share Capital ⓘ	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Reserves ⓘ	0.21	0.23	0.29	0.33	0.35	0.38	0.40
Minority Interest	0	0	0	0	0	0	0
Debt	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0	0	0
Trade Payables	0	0	0	0	0	0	0
Others Liabilities ⓘ	0.02	0.02	0.01	0.03	0.01	-0.01	-0.01
Total Liabilities ⓘ	0.28	0.31	0.35	0.41	0.41	0.42	0.44
Fixed Assets
Gross Block	0	0	0	0	0	0	0
Accumulated Depreciation	0	0	0	0	0	0	0
Net Fixed Assetsⓘ	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0.31	0.28	0.29	0
Inventories	0	0	0	0	0	0	0
Trade Receivables	0	0	0	0	0	0	0
Cash Equivalents	0.24	0.27	0.31	0.06	0.10	0.11	0.13
Others Assetsⓘ	0.03	0.03	0.04	0.05	0.04	0.01	0.31
Total Assets ⓘ	0.28	0.31	0.35	0.41	0.41	0.42	0.44

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Dec'08	Dec'09	Mar'14	Mar'15	Mar'16	Mar'17
Cash Flow From Operating Activity ⓘ	0.02	0.01	0.02	0.01	0.01	0.01
PBT ⓘ	0.02	0.03	-0.01	0.02	0.03	0.03
Adjustment ⓘ	0	-0.01	0.04	-0.01	-0.02	-0.01
Changes in Working Capital ⓘ	0	-0	0	0	0	0
Tax Paid ⓘ	-0.01	-0.01	0	0	0	0
Cash Flow From Investing Activity ⓘ	-0.03	-0.03	0	-0.04	0.01	0.01
Capex	0	0	0	0	0	0
Net Investments	-0.04	-0.04	0	-0.07	-0.07	-0.07
Others ⓘ	0.01	0.01	0	0.03	0.08	0.08
Cash Flow From Financing Activityⓘ	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0
Net Cash Flow ⓘ	-0.02	-0.01	0.02	-0.03	0.02	0.02

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Dec'08	Dec'09	Dec'10	Mar'14	Mar'15	Mar'16	Mar'17
Ratios
ROE (%)	6.94	9.69	19.29	-6.08	5.07	5.99	4.5
ROCE (%)	8.04	11.2	11.07	-3.73	5.83	8.78	6.1
Asset Turnover Ratio	0	0	0	0.08	0.06	0.06	0.06
PAT to CFO Conversion(x)	1	0.33	0.33	N/A	0.5	0.5	0
Working Capital Days
Receivable Days	0	0	0	0	0	0	0
Inventory Days	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0

Gufic Pharma Ltd. - (Amalgamated) Stock News

Gufic Pharma Ltd. - (Amalgamated) FAQs

What is the share price of Gufic Pharma Ltd.?

Company share prices are keep on changing according to the market conditions. The closing price of Gufic Pharma Ltd. on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Gufic Pharma Ltd.?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Gufic Pharma Ltd. stood at ₹0.00.